PharmaTimes Clinical Researcher of the Year Winners!

Covance Takes Home Two Gold Awards in Annual PharmaTimes Competition

在完成一个严谨、三级competition that included multiple choice questions, a written essay and a set of final challenges to evaluate clinical researchers’ skills in a professional setting, the PharmaTimes Clinical Researcher of the Year awards results are in: Covance employees Julianne Gardner, a senior clinical team lead (CTL) in the U.S., and Gemma Cowley, a clinical research associate I (CRA I) in the U.K., were named gold winners.

The leadership team at Covance, the drug development business of Labcorp, was thrilled to congratulate the winners, including additional silver and bronze winners and finalists from the U.S. and U.K., as well as Chile, Mexico, Peru, Poland, Belgium, Italy, Scotland, Ireland and Australia.

“In such an unprecedented year, it’s more meaningful than ever to celebrate our finalists and winners,” said Mark Morais, president of clinical operations and commercial solutions. “These colleagues represent our commitment, perseverance, and dedication to the patients and clients we serve.

“他们代表了一种崛起的文化,并体现了患者等不及的信念,我们也不能做。祝贺所有决赛者 - 我们为你和在一起为此感到骄傲,“我们有这个。”

Meet Julianne: Clinical Trial Manager of the Year

Julianne, who was named the first placePharmatimes 2020年临床试验经理 - 美洲, started her career here approximately five years ago as a CRA I, progressed through the ranks to a CTL in May 2019 and received a promotion to senior CTL in September 2020. She was also recognized by PharmaTimes as the first place Experienced CRA of the Year – Americas in 2019.

“I’ve always known the CRA role was a stepping stone for me and that I wanted to go into the management side of things,” she said. “Once I was able to develop enough rapport with some of our CTLs who trusted me and my work, I started asking if there was anything I could help them with on a regular basis. The resulting mentorship and visibility I received into their roles was really helpful.”

Currently, as a CTL in the medical device group, she’s able to combine her scientific interest with her business acumen and develop new skills. Julianne shared that she appreciates working on global projects and collaborating with people with different viewpoints and backgrounds. She also enjoys seeing clinical trials come together from the beginning and building trust with her teams of CRAs.

Meet Gemma: Clinical Trial Administrator of the Year

Gemma被命名为第一名Pharmatimes 2020年度国际临床试验管理人员,加入卓越监测卓越学院,担任临床试验管理员(CTA)大约两年,然后在我们的专职赞助商角色晋升到CRA I之前Functional Service Provider (FSPx)business in July 2020.

“Having been a CTA before a CRA, I have a greater appreciation for the significance of a CTA in a clinical trial team, and how critical their work is to ensure the study is regulatory and GCP compliant,” she said. “I actually stayed in the CTA role slightly longer than our training program requires because I wanted to fully understand the role, but I always knew I would prefer to be more involved with the ‘science behind the trials’ than that role offered.”

目前,Gemma喜欢在新的CRA角色中与医院合作,日益了解她对医疗程序的理解及其在她管理的审判中的影响,并直接与调查人员和临床医生一起工作。亚博全站官网

“我现在可以理解,”她说,“作为临床试验的最前沿的CRA,它如何感觉如何成为最重要的作用。但是,实际上,整个团队至关重要。CTA已经开展了大量工作,以使研究能够建立,并且他们将继续在后台进行重要和重要的工作。“

Learn more about our career growth opportunities forclinical research associatesand加入我们的人才网络to be the first to learn about new roles.

You may also like...

流行文章......